Advertisements

Dr.Reddy’s to sell generic version of opioid addiction treatment Suboxone in U.S.

Dr.Reddy’s to sell generic version of opioid addiction treatment Suboxone in U.S......»»

Category: topSource: the-hinduJun 15th, 2018

U.S. court allows generic version of Indivior opioid abuse drug

U.S. court allows generic version of Indivior opioid abuse drug.....»»

Category: global-financeSource: reutersNov 20th, 2018

Dr.Reddy’s to sell generic version of opioid addiction treatment Suboxone in U.S.

Dr.Reddy’s to sell generic version of opioid addiction treatment Suboxone in U.S......»»

Category: topSource: the-hinduJun 15th, 2018

Indivior plans cheaper opioid addiction drug if rivals launch copycats

Indivior plans cheaper opioid addiction drug if rivals launch copycats.....»»

Category: global-financeSource: reutersDec 18th, 2018

Indivior says wins fresh hold on Suboxone copy

Indivior says wins fresh hold on Suboxone copy.....»»

Category: global-financeSource: reutersDec 12th, 2018

Indivior sticks to FY outlook, warns of hit from generic rival

Indivior sticks to FY outlook, warns of hit from generic rival.....»»

Category: global-financeSource: reutersNov 21st, 2018

U.S. court expedites Indivior rival Dr. Reddy"s appeal to re-launch generic drug

U.S. court expedites Indivior rival Dr. Reddy"s appeal to re-launch generic drug.....»»

Category: global-financeSource: reutersJul 30th, 2018

US court prevents Dr Reddy"s from launching opioid treatment drug Suboxone - The Hindu

US court prevents Dr Reddy"s from launching opioid treatment drug Suboxone - The Hindu.....»»

Category: topSource: googlenewsJul 14th, 2018

Indivior shares dive after Dr Reddy"s gets FDA approval for generic

Indivior shares dive after Dr Reddy"s gets FDA approval for generic.....»»

Category: global-financeSource: reutersJun 15th, 2018

Dr.Reddy"s Laboratories launches generic version of Suboxone

Dr.Reddy"s Laboratories launches generic version of Suboxone.....»»

Category: topSource: the-hinduJun 15th, 2018

Indivior wins fresh hold on Dr. Reddy"s Suboxone copy

Indivior wins fresh hold on Dr. Reddy"s Suboxone copy.....»»

Category: global-financeSource: reutersDec 12th, 2018

Indivior says U.S. court rules against generic rival"s appeal

Indivior says U.S. court rules against generic rival"s appeal.....»»

Category: global-financeSource: reutersJul 31st, 2018

Dr. Reddy"s first-quarter net profit rises seven-fold, beats forecast

Dr. Reddy"s first-quarter net profit rises seven-fold, beats forecast.....»»

Category: global-financeSource: reutersJul 26th, 2018

US court restrains DRL"s sale of Suboxone anti-opioid copy - The Hindu

US court restrains DRL"s sale of Suboxone anti-opioid copy - The Hindu.....»»

Category: topSource: googlenewsJul 14th, 2018

Indivior wins preliminary injunction against generic rival

Indivior wins preliminary injunction against generic rival.....»»

Category: global-financeSource: reutersJul 14th, 2018

Indivior gets breather after court extends order blocking generic rival

Indivior gets breather after court extends order blocking generic rival.....»»

Category: global-financeSource: reutersJun 29th, 2018

Indivior files lawsuits against Suboxone generic rivals

Indivior files lawsuits against Suboxone generic rivals.....»»

Category: global-financeSource: reutersSep 15th, 2017

Indivior files patent lawsuits against generic Suboxone rivals

Indivior files patent lawsuits against generic Suboxone rivals.....»»

Category: global-financeSource: reutersSep 15th, 2017

Indivior loses U.S. district court battle, copycat launches imminent

Indivior loses U.S. district court battle, copycat launches imminent.....»»

Category: global-financeSource: reutersFeb 12th, 2019

Indivior temporarily stops rival Alvogen"s generic launch

Indivior temporarily stops rival Alvogen"s generic launch.....»»

Category: global-financeSource: reutersJan 25th, 2019

Indivior to launch cheaper opioid addiction drug; maintains forecast

Indivior to launch cheaper opioid addiction drug; maintains forecast.....»»

Category: global-financeSource: reutersDec 18th, 2018